Literature DB >> 6427385

Activation of B lymphocytes by monovalent anti-Lyb-2 antibodies.

B Subbarao, D E Mosier.   

Abstract

Although activation of B lymphocytes by antigen or anti-Ig antibody has been shown to require cross-linking of surface Ig molecules, cross-linking is not necessary for B cell activation by anti-Lyb-2 monoclonal antibody (MAb). Monovalent Fab' fragments of anti-Lyb-2 MAb are as effective as the intact antibody in inducing blast cell transformation of small B cells and B cell proliferation in the apparent absence of T cells and adherent cells. In the presence of factors from T cells, B cells activated by Fab' fragments of anti-Lyb-2 MAb were induced to mature into Ig-secreting cells. Since monovalent Fab' fragments probably cannot induce receptor aggregation, it appears that receptor occupancy is sufficient to induce B cell activation with anti-Lyb-2 MAb.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6427385      PMCID: PMC2187309          DOI: 10.1084/jem.159.6.1796

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Separation of univalent fragments from the bivalent rabbit antibody molecule by reduction of disulfide bonds.

Authors:  A NISONOFF; F C WISSLER; L N LIPMAN; D L WOERNLEY
Journal:  Arch Biochem Biophys       Date:  1960-08       Impact factor: 4.013

2.  Selective triggering of B cell subpopulations by mitogens.

Authors:  E Gronowicz; A Coutinho
Journal:  Eur J Immunol       Date:  1974-11       Impact factor: 5.532

3.  Induction of immunoglobulin and antibody synthesis in vitro by lipopolysaccharides.

Authors:  J Andersson; O Sjöberg; G Möller
Journal:  Eur J Immunol       Date:  1972-08       Impact factor: 5.532

4.  Separation of mouse spleen cells by passage through columns of sephadex G-10.

Authors:  I A Ly; R I Mishell
Journal:  J Immunol Methods       Date:  1974-08       Impact factor: 2.303

5.  Requirement for cross-linkage in the stimulation of transformation of rabbit peripheral lymphocytes by antiglobulin reagents.

Authors:  M W Fanger; D A Hart; J V Wells; A Nisonoff
Journal:  J Immunol       Date:  1970-12       Impact factor: 5.422

6.  A plaque assay for all cells secreting Ig of a given type or class.

Authors:  E Gronowicz; A Coutinho; F Melchers
Journal:  Eur J Immunol       Date:  1976-08       Impact factor: 5.532

Review 7.  Separate signals for the initiation of proliferation and differentiation in the b cell response to antigen.

Authors:  R W Dutton
Journal:  Transplant Rev       Date:  1975

8.  Anti-immunoglobulin stimulation of murine lymphocytes. II. Identification of cell surface target molecules and requirements for cross-linkage.

Authors:  H L Weiner; J W Moorhead; K Yamaga; R T Kubo
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

9.  Regulation of antibody response in vitro. IX. Induction of secondary anti-hapten IgG antibody response by anti-immunoglobulin and enhancing soluble factor.

Authors:  T Kishimoto; K Ishizaka
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

10.  Autoradiographic studies on the proliferation of antibody-producing cells in vitro.

Authors:  T Hünig; A Schimpl; E Wecker
Journal:  J Exp Med       Date:  1974-03-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Positive and negative roles of CD72 in B cell function.

Authors:  Hsin-Jung Wu; Subbarao Bondada
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Sequence of the Lyb-2 B-cell differentiation antigen defines a gene superfamily of receptors with inverted membrane orientation.

Authors:  E Nakayama; I von Hoegen; J R Parnes
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

Review 3.  Functional B-lymphocyte surface antigens.

Authors:  J T Golay
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

4.  Control of human B-lymphocyte replication. I. Characterization of novel activation states that precede the entry of G0 B cells into cycle.

Authors:  L Walker; G Guy; G Brown; M Rowe; A E Milner; J Gordon
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

5.  Structural features of the Lyb-2 molecule.

Authors:  T Ashida; H Yakura; I Kawabata; M Murakami; M Katagiri
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

6.  Expansion of CD8+ T cells lacking Sema4D/CD100 during HIV-1 infection identifies a subset of T cells with decreased functional capacity.

Authors:  Emily M Eriksson; Jeffrey M Milush; Emily L Ho; Mariana D Batista; Sara J Holditch; Chris E Keh; Philip J Norris; Sheila M Keating; Steven G Deeks; Peter W Hunt; Jeffrey N Martin; Michael G Rosenberg; Frederick M Hecht; Douglas F Nixon
Journal:  Blood       Date:  2011-12-01       Impact factor: 22.113

7.  Occupancy of CD72 (the CD5 counterstructure) enhances interleukin-4-dependent CD23 expression in resting B lymphocytes.

Authors:  A Katira; M Kamal; J Gordon
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

8.  Triggering of B lymphocytes through CD23: epitope mapping and studies using antibody derivatives indicate an allosteric mechanism of signalling.

Authors:  J Gordon; A J Webb; G R Guy; L Walker
Journal:  Immunology       Date:  1987-04       Impact factor: 7.397

9.  CD72 negatively regulates KIT-mediated responses in human mast cells.

Authors:  Tatsuki R Kataoka; Atsushi Kumanogoh; Geethani Bandara; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  J Immunol       Date:  2010-01-25       Impact factor: 5.422

10.  CD72, a coreceptor with both positive and negative effects on B lymphocyte development and function.

Authors:  Hsin-Jung Wu; Subbarao Bondada
Journal:  J Clin Immunol       Date:  2008-12-06       Impact factor: 8.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.